Company: LRHC
Filing Date: 2025-07-11
Form Type: PRE 14C
Source: 0001213900-25-063319
Chunk: 5

Company: La Rosa Holdings Corp.
Filing Date: 2025-07-11
Form: PRE 14C
Chunk 5
---
 beneficial owners of our voting securities held of record by them and we will reimburse such
persons for out-of-pocket expenses incurred in forwarding such material.

<div align='center'>1

WE ARE NOT ASKING YOU FOR A PROXY, AND

YOU ARE REQUESTED NOT TO SEND US A PROXY.

ACTIONS TAKEN</div>

This Information Statement
contains a brief summary of the material aspects of the Corporate Actions approved by the members of the Board of Directors and the Majority
Stockholders.

1. APPROVAL OF THE ISSUANCE OF NEW CONVERSION SHARES IN EXCESS OF 19.99% OF THE COMPANY’S ISSUED AND OUTSTANDING COMMON STOCK IN COMPLIANCE WITH NASDAQ’S 20% RULE

On February 4, 2025, the Company
and an institutional investor (the “Investor”) entered into a Securities Purchase Agreement (the “Securities Purchase
Agreement”) pursuant to which the Company issued to the Investor: (i) a Senior Secured Convertible Note in the original principal
amount of $5,500,000 which matures on the two-year anniversary of the Closing Date (the “Initial Note”); and (ii) sixteen
(16) warrants (each an “Incremental Warrant”; and collectively “Incremental Warrants”), each to purchase additional
Senior Secured Convertible Notes of the Company in an original principal amount up to $2,500,000 at an exercise price of $2,256,250 in
substantially the same form as the Initial Note (“Incremental Notes”; and together with the Initial Note, the “Notes”).
The purchase price paid by the Investor under the Securities Purchase Agreement for the Initial Note and Incremental Warrants was $4,963,750.

On June 18, 2025, with the
prior approval by the Board of Directors, the Company and the Investor entered into, and closed the transactions contemplated by, that
certain Amendment and Exchange Agreement (the “Exchange Agreement”) pursuant to which (among other things) the Investor surrendered
and exchanged all of its Incremental Warrants in exchange for (the “Exchange”) 6,000 shares of the Company’s Series
B Convertible Preferred Stock (“New Preferred Shares”), par value $0.0001 per share (“Series B Preferred Stock”).
On the same date, the Company filed a Certificate of Designation of Rights and Preferences of the Series B Preferred Stock (the “Certificate
of Designation”) with the